Share class: Cosmos Health Inc.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A160,043,49139,580,591 ( 65.92 %) 86,497 ( 0.1441 %) 65.92 %

Major shareholders: Cosmos Health Inc.

NameStocks%Valuation
21.72 %
13,481,808 21.72 % 3 M $
6.966 %
4,324,197 6.966 % 1 M $
3.601 %
2,235,398 3.601 % 552 143 $
Renaissance Technologies LLC
0.629 %
390,500 0.629 % 96 454 $
Geode Capital Management LLC
0.5124 %
318,111 0.5124 % 78 573 $
BlackRock Institutional Trust Co. NA
0.4314 %
267,797 0.4314 % 66 146 $
Vanguard Capital Management LLC
0.2255 %
140,007 0.2255 % 34 582 $
0.1611 %
100,000 0.1611 % 24 700 $
Vanguard Fiduciary Trust Co.
0.1542 %
95,735 0.1542 % 23 647 $
HRT Financial LP
0.1084 %
67,280 0.1084 % 16 618 $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Individuals32.85%
Institutional1.71%
Others0.59%
State Street Corp.0.07%
Unknown64.78%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals
32.85%
United States
2.3%
Cayman Islands
0.07%
Canada
0.01%

Based on 1000 largest holdings

Logo Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
163